Medipal Holdings Corp.

Industry

  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Services
  • Distributors

Other Names/Subsidiaries

  • ASTEC
  • MEDIE
  • PreMedica
  • Presuscube
See more in Biomedtracker

Latest on Medipal Holdings Corp.

Scrip

Finance Watch: Venture Capital Dominates Biopharma Funding So Far In 2022

 
• By Mandy Jackson and Ian Haydock

Even with less venture capital raised during the first quarter of 2022 than in Q1 of 2021, VC financing has become the most common type of financing for biopharmaceutical firms raising cash in 2022, a

Pink Sheet

Yescarta Becomes Japan’s Second Approved CAR-T

 
• By Ian Haydock

The latest batch of product approvals in Japan includes Daiichi Sankyo Co., Ltd. ’s CD19-targeting cancer therapy Yescarta (axicabtagene ciloleucel), making this the second chimeric antigen receptor

Scrip

Asia Deal Watch: Fujifilm Affiliate Out-Licenses Antifungal Candidate To Canada’s Appili

 
• By Ian Haydock, Joseph Haas, Vibha Ravi, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Appili Gains Rights To FUJIF

Scrip

Venture Funding Deals: Takeda's Phathom Raises $140m In Crossover Round For GERD Program

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmace